Grifols SA
Grifols SA is a Healthcare company operating in Drug Manufacturers - General with a $6.02B market cap.
Behavioral analysis
Disclosures
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks GIFOF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GIFOF.
$ curl https://api.spokenalpha.com/v1/companies/GIFOFFAQ
Spoken Alpha indexes GIFOF's earnings call transcripts at https://spokenalpha.com/companies/GIFOF. Each call links to attributed speakers and parsed analyst Q&A.
Grifols SA (GIFOF) operates in the Healthcare sector (Drug Manufacturers - General industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.93 | $3.08 | +27.6% | -2.5% | -5.2% |
| Q4 FY2026 | $4.24 | $3.19 | +32.9% | +2.8% | +4.1% |
| Q3 FY2026 | $3.99 | $3.29 | +21.3% | -0.7% | -3.2% |
| Q2 FY2026 | $4.15 | $3.38 | +22.7% | +8.6% | +11.2% |
| Q1 FY2025 | $3.76 | $3.20 | +17.6% | +2.2% | +0.7% |
| Q4 FY2025 |
| $4.05 |
| $3.40 |
| +19.2% |
| +8.4% |
| +7.6% |
| Q3 FY2025 | $4.25 | $3.29 | +29.2% | +1.4% | -0.2% |
| Q2 FY2025 | $3.99 | $3.33 | +19.7% | +2.4% | +2.7% |
| Q1 FY2024 | $4.52 | $3.39 | +33.3% | +1.9% | +3.4% |
| Q4 FY2024 | $4.13 | $3.24 | +27.6% | +2.1% | +3.4% |